Page 25 - Essentia Vol 5 Issue 1
P. 25

VOL V | ISSUE I | 5 AUGUST 2026  VOL V | ISSUE I | 5 AUGUST 2026
 A BIANNUAL NEWSLETTER OF ASSAM CANCER CARE FOUNDATION                                 A BIANNUAL NEWSLETTER OF ASSAM CANCER CARE FOUNDATION



             When Cure

             Was Beyond Reach,


             Hope Was Not



             A Journey with Palliative
             Radiotherapy and
             Metronomic Chemotherapy







                                       Lt Col (Dr) Nishant Lohia
                                       Consultant, Radiation Oncologist  Cancer should challenge the disease
                                       Kokrajhar Cancer Centre              not the dignity, livelihood,
                                                                         or future of the family fighting it.



                    ancer  care  is  often  associated  with    psychological  distress.  At  this  stage,  treatment
                    advanced  therapies,  targeted  drugs  and   focused  on  palliation:  controlling  symptoms,
             Cimmunotherapy.  While  these  treatments          preventing  further  complications  and  improving
             have  improved  outcomes  for  many  patients,     quality of life.
             access  remains  difficult  for  several  families  in
             resource-limited  settings.  Even  then,  meaningful   The treatment approach
             benefit can often be achieved through affordable,   The patient received palliative radiotherapy to the
             carefully planned treatment.                       neck  mass,  followed  by  maintenance  treatment
             This  case  shows  how  palliative  radiotherapy  and   with oral metronomic chemotherapy.
             oral metronomic chemotherapy (OMCT) can offer      The  treatment  plan  was  designed  to  balance
             symptom relief, disease control and dignity when   disease  control,  financial  constraints  and  the
             cure is no longer the primary goal.                patient’s quality of life.


              The challenge
                                                                 What is Oral Metronomic
             A  middle-aged  man  from  a  socio-economically
             disadvantaged  background  presented  with  a  large  Chemotherapy?
             fungating  malignant  growth  on  the  left  side  of  the
             neck and lower face. Over several months, the tumour   Metronomic chemotherapy involves
             had caused pain, bleeding, foul-smelling discharge,   giving low-dose oral anticancer
             difficulty in daily activities and social embarrassment.  medicines continuously over a longer
             The  disease  was  locally  advanced,  and  his     period. It is relatively affordable,
             financial  situation  limited  access  to  newer    convenient and may help slow tumour
             systemic  therapies  such  as  immunotherapy.  The   growth while keeping side effects
             visible  tumour  also  led  to  social  isolation  and   manageable.




 24                                        The greatest victories begin with hope.                          25
   20   21   22   23   24   25   26   27   28   29   30